IJR News — today's news from every sidePriya Raman A 35B valuation looks steep with those losses, but Nvidia backing could still pull in plenty of buyers. United Therapeutics and Denali Outline Pipeline Shifts at Morgan Stanley Conference — 4dBiotech firms Crescent Biopharma, Denali Therapeutics, Kyverna Therapeutics, and United Therapeutics outlined forthcoming data, new indications, and expansive commercial strategies at the Morgan Stanley Global Healthcare Conference, signaling a push into pulmonary fibrosis, CNS, and other large patient populations. Denali highlighted its Avlayah Transport Vehicle platform and CNS programs, while United Therapeutics outlined a four‑product strategy for IPF/PPF and planned NDA activities, underscoring continued innovation and manufacturing expansion across the sector.
Nicole Hardy Shifting focus to larger populations like pulmonary fibrosis makes sense for growth but competition will be fierce.Dana Whitfield Reaching 17 billion by 2040 depends on hitting those production numbers, which Tesla has struggled with before. 
OpenAI launches ChatGPT for Financial Services aimed at Wall Street tasks — Sep 10, 2026OpenAI has rolled out ChatGPT for Financial Services, a tailored enterprise product powered by GPT-6 Astra that combines its AI with data from vendors like LSEG, PitchBook, and Daloopa, developed with Morgan Stanley and Evercore as design partners to aid analysts, researchers, and presentation work for Wall Street. The offering emphasizes governance and compliance—role-based access, encryption, and exportable logs—while enabling firms to integrate their existing data subscriptions and extend coverage across multiple sources to improve retrieval, citation, and client-material generation.
Priya Raman This integration with LSEG and PitchBook data could finally cut down the time analysts spend hunting across separate platforms.Anthropic nears $15 billion credit facility ahead of possible IPO — Sep 3, 2026Anthropic is close to securing a $15 billion revolving credit facility ahead of an anticipated IPO, led by Morgan Stanley with Goldman Sachs, JPMorgan Chase and Citigroup involved, and a broad roster of banks including Barclays, Wells Fargo, Bank of America, Deutsche Bank, RBC, and UBS. The massive line serves as a liquidity backstop to support operations and financing needs during the IPO process, potentially shaping the deal structure and market expectations for Anthropic’s public offering.
Dana Whitfield Feels like the credit facility is designed to make the IPO look stronger than it actually is on day one.Vor Bio to Join Wells Fargo, Citi and Other September Conferences — Aug 31, 2026Biotech companies Conexeu Sciences, Vor Bio, Cabaletta Bio, and Jade Biosciences announced plans to participate in a string of September–October 2026 investor conferences, including management presentations, one-on-one meetings, and webcasted fireside chats across major events such as Wells Fargo, Citi, Morgan Stanley, Cantor, and others. The companies emphasize investor engagement and webcast availability as they push forward their autoimmune disease programs and tissue-restoration platforms.
Lido Advisors trims holdings across funds, Morgan Stanley — Jul 23, 2026Lido Advisors LLC trimmed multiple holdings in Q1, including selling 47,324 Morgan Stanley shares and 116,899 iShares MSCI ACWI ETF shares, as well as reducing Vanguard Russell 2000 ETF by 44,696 shares, State Street SPDR Portfolio S&P 500 ETF by 274,937 shares, and iShares Russell Mid-Cap Growth ETF by 11,055 shares. The firm’s remaining positions across these funds remained sizable, reflecting broad adjustments among its diversified stock and ETF holdings.
